Complete remission of idiopathic myelofibrosis following donor lymphocyte infusion after failure of allogeneic transplantation: Demonstration of a graft-versus-myelofibrosis effect

Bone Marrow Transplantation

Volumn 26, Issue 6, 2000, Pages 697-699

  Cervantes, F ^a   Rovira, M ^a   Urbano Ispizua, A ^a   Rozman, M ^a   Carreras, E ^a   Montserrat, E ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Agnogenic myeloid metaplasia; Allogeneic transplantation; Donor lymphocyte infusion; Graft versus disease effect; Graft versus host disease; Idiopathic myelofibrosis

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; METHYLPREDNISOLONE;

ADULT; ALLOTRANSPLANTATION; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CELL CLONE; CHIMERA; CLINICAL FEATURE; DONOR; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LYMPHOCYTE TRANSFUSION; MYELOFIBROSIS; OSTEOSCLEROSIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REMISSION; SKIN MANIFESTATION; TREATMENT FAILURE;

EID: 0033794885     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1702568     Document Type: Article

References (10)

1. Myelofibrosis: Clinical, hematologic and pathologic study of 110 patients
2. Agnogenic myeloid metaplasia: A clonal proliferation of hemopoietic stem cells with secondary myelofibrosis
3. Myelofibrosis with myeloid metaplasia: Diagnostic definition and prognostic classification for clinical studies and treatment guidelines
4. Myelofibrosis with myeloid metaplasia in young individuals: Disease characteristics, prognostic factors and identification of risk groups
5. Allogeneic stem cell transplantation for agnogenic myeloid metaplasia: A European group for blood and marrow transplantation
6. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients
7. Donor lymphocyte infusions
8. Induction of graft-versus-host-disease as immunotherapy for relapsed chronic myeloid leukemia
9. Cytogenetic studies and their prognostic significance in agnogenic myeloid metaplasia: A report on 47 cases
10. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases